Marker Therapeutics (MRKR) Q4 2024 Earnings

Nov 14Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.43
-0.37
-0.31
-0.25

Details

Expected EPS
-0.39
Actual EPS
-0.26
Surprise EPS
0.13
Surprise Percent
+33.33%

Description

⁨Marker Therapeutics⁩ (⁦MRKR⁩) has reported earnings of ⁦-0.26⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts